First-Line Carboplatin and Pemetrexed With Pembrolizumab for NSCLC
June 21st 2017Leena Gandhi, MD, PhD, director of the Thoracic Medical Oncology Program at NYU Langone School of Medicine, discusses first-line carboplatin and pemetrexed with or without pembrolizumab for advanced nonsquamous non–small cell lung cancer.